About Us

USV Limited is a leading pharmaceutical company having established as number one in OAD ( Oral Anti- Diabetic) by both Rx and Value, Number one in CV(Cardio Vascular) in Rx and amongst the first eight companies by value. Our product offering today includes Active Pharmaceutical Ingredients (APIs), Peptides, Biosimilars, Injectables and Ophthalmics and Solid Orals. These are manufactured in our cGMP compliant plants located in India.

We market our products globally to 75 countries. In the financial year 2013-14, our total revenue was Rs. 19,991 million. Our Indian Business contributed 78% to the revenue and the rest was from Export of APIs and Finished Dosages.

We also have significant presence in the areas of Gynaecology, Dermatology, Gastroenterology and general practice.

Our international business consists of:

• • A large portfolio of small molecule APIs. Of the 52 products in our portfolio, 27 APIs are commercially available, with others in various stages of development. Our special skills include production and characterization of polymorphs and particle sizing.
• • A portfolio of Finished Dosages. These include immediate release, modified release and products with ‘complex’ characteristics which are promoted through ANDA filings and Dossiers linked to supply.

Our spend of 5% of sales on R&D ensures that we are able to deliver on our research portfolio. We have over 100,000 sq. ft. of laboratory space with excellent infrastructure. Our research is driven by a team of 259 scientists including 2 doctors, 32 PhDs and 180 post-graduates, many of whom have studied in universities in USA, Europe and Japan. Our intellectual property portfolio consists of 50 patent filings of which 17 have been granted.